Literature DB >> 18557605

Brassinosteroids: synthesis and activity of some fluoro analogues.

Barbora Slavikova1, Ladislav Kohout, Milos Budesinsky, Jana Swaczynova, Alexander Kasal.   

Abstract

Three types of 5alpha-androstane and ergostane analogues of brassinolide, containing a fluorine atom in either the 3alpha or the 5alpha positions or in 3alpha and 5alpha positions, were prepared using standard operations (reaction of 3beta-alcohols with (diethylamino)sulfur trifluoride, cleavage of epoxide with HF in py or BF 3.Et 2O). The 5alpha-fluorine was found to affect chemical reactivity (e.g., electrophilic addition to the Delta (2)-double bond) as well as physical properties (e.g., NMR, chromatographic behavior) of the products. Cytotoxicity of the products was studied using human normal and cancer cell lines with 28-homocastasterone as positive control and their brassinolide type activity was established using the bean second-internode test with 24-epibrassinolide as standard. The equivalence of F and OH groups was observed in some of the active compounds. The anticancer and the brassinolide-type activity do not correlate with each other: ergostane derivatives were most active in the former test while androstane derivatives were best in the latter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18557605     DOI: 10.1021/jm800085p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  24-Epibrassinolide, a Phytosterol from the Brassinosteroid Family, Protects Dopaminergic Cells against MPP-Induced Oxidative Stress and Apoptosis.

Authors:  Julie Carange; Fanny Longpré; Benoit Daoust; Maria-Grazia Martinoli
Journal:  J Toxicol       Date:  2011-06-03

2.  Insights into the Structural Requirements of Potent Brassinosteroids as Vegetable Growth Promoters Using Second-Internode Elongation as Biological Activity: CoMFA and CoMSIA Studies.

Authors:  Karoll Ferrer-Pertuz; Luis Espinoza; Jaime Mella
Journal:  Int J Mol Sci       Date:  2017-12-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.